A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...

Add-on therapy and substitution monotherapy are both effective second-line treatments for women with idiopathic generalized epilepsy.

Counties designated as maternity care deserts face significantly higher maternal mortality rates than those with full access ...

Buying too early or too late could hit your wallet, as well as running the risk that your child outgrows what you bought. One ...

According to atai Life Sciences, a single dose of an investigational intranasal formulation of mebufotenin benzoate, a ...

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...

FinanceBuzz looked at theme park admission prices to find where prices have risen the most and least. See if ticket prices ...

Explore Mesoblast Limited's advancements in cell therapies, from FDA alignments to key trials. Click for MESO opportunities ...

In this interview, AZoMaterials speaks with an expert from Malvern Panalytical, a company at the forefront of light scattering innovation, to explore the technique's current landscape and future ...

Triple Pressures Weigh on Aluminum Prices, Low Inventory Support Intensifies Market Game] On the macro front, Trump plans to impose tariffs of up to 70% on multiple countries, coupled with a deadlock ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

RONALD MUSOKE | Palabek Secondary School in the northern Uganda district of Lamwo near the South Sudan border has become the ...